Long Term Follow-Up of Patients with Systemic Right Ventricle and Biventricular Physiology: A Single Centre

Cristina Ciuca1, Anna Balducci1, Emanuela Angeli2

  • 1Pediatric Cardiology and Adult Congenital Heart Disease Program, Department of Cardio-Thoracic and Vascular Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Insights

Adults with a systemic right ventricle (SRV) face frequent clinical events like arrhythmias and heart failure. Long-term monitoring is crucial for managing these congenital heart disease cases.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease
  • Cardiac Surgery

Background:

  • Congenital heart disease (CHD) is increasingly diagnosed in adults.
  • Systemic right ventricle (SRV) associated CHD cases have poorer prognoses.
  • Understanding long-term outcomes in SRV patients is critical.

Purpose of the Study:

  • To evaluate the long-term clinical outcomes and adverse events in adult patients with SRV.
  • To compare outcomes between different etiologies of SRV (transposition of the great arteries vs. congenitally corrected transposition).

Main Methods:

  • Retrospective analysis of 73 SRV patients evaluated between 2014-2020.
  • Included patients with transposition of the great arteries (atrial switch) and congenitally corrected transposition (ccTGA).
  • Follow-up data on clinical events, hospitalizations, and survival were analyzed.

Main Results:

  • High incidence of clinical events, primarily arrhythmias (27.1%) and heart failure (12.3%).
  • Six-year event-free survival was 90%; no significant difference between SRV groups.
  • Late gadolinium enhancement (LGE), lower exercise capacity, higher NYHA class, and RV dilation/hypokinesis predicted poorer outcomes.

Conclusions:

  • Long-term follow-up of SRV patients is marked by significant clinical events, mainly arrhythmias and heart failure.
  • These events lead to frequent unscheduled hospitalizations.
  • Despite event incidence, overall survival remains high, but risk factors for adverse outcomes require attention.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
19
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
20
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12